Chemoinformaics analysis of 2-Methylanthracene
Molecular Weight | 192.261 | nRot | 0 |
Heavy Atom Molecular Weight | 180.165 | nRig | 16 |
Exact Molecular Weight | 192.094 | nRing | 3 |
Solubility: LogS | -6.492 | nHRing | 0 |
Solubility: LogP | 4.87 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 3 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 0 | No. of Arom Bond | 16 |
nHA | 0 | APOL | 33.0515 |
nHD | 0 | BPOL | 12.0385 |
QED | 0.466 |
Synth | 1.559 |
Natural Product Likeliness | -0.323 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.035 |
Pgp-sub | 0.061 |
HIA | 0.003 |
CACO-2 | -4.544 |
MDCK | 0.0000155 |
BBB | 0.618 |
PPB | 0.98284 |
VDSS | 0.917 |
FU | 0.0182562 |
CYP1A2-inh | 0.967 |
CYP1A2-sub | 0.407 |
CYP2c19-inh | 0.623 |
CYP2c19-sub | 0.119 |
CYP2c9-inh | 0.37 |
CYP2c9-sub | 0.804 |
CYP2d6-inh | 0.546 |
CYP2d6-sub | 0.902 |
CYP3a4-inh | 0.362 |
CYP3a4-sub | 0.243 |
CL | 9.409 |
T12 | 0.231 |
hERG | 0.173 |
Ames | 0.882 |
ROA | 0.067 |
SkinSen | 0.946 |
Carcinogencity | 0.86 |
EI | 0.993 |
Respiratory | 0.038 |
NR-Aromatase | 0.076 |
Antiviral | Yes |
Prediction | 0.638697 |